Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration - Trial NCT03333954
Access comprehensive clinical trial information for NCT03333954 through Pure Global AI's free database. This phase not specified trial is sponsored by Pixium Vision SA and is currently Active, not recruiting. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 5 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pixium Vision SA
Timeline & Enrollment
N/A
Nov 06, 2017
Aug 27, 2024
Primary Outcome
Elicitation of perception,Elicitation of perception,Elicitation of perception,Elicitation of perception,Elicitation of perception,Elicitation of perception,Elicitation of perception
Summary
In this study, the principle functionality of the device will be tested in humans for the
 first time. The study will evaluate the extent to which patients with atrophic dry age
 related macular degeneration (AMD) have evoked light perception using the implant.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03333954
Device Trial